Press Releases
🇺🇸 FDA Page 9FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 97–108 of 212 articles
Jazz Pharmaceuticals' Ziihera Gets FDA Priority Review for First-Line HER2+ Cancer Treatment
NCCN Adds Nuvation Bio's Taletrectinib (IBTROZI) to Cancer Treatment Guidelines for ROS1-Positive NSCLC with Brain Metastases
FDA Grants Priority Review for IMAAVY (Nipocalimab-aahu) as First Potential Treatment for Warm Autoimmune Hemolytic Anemia
Apotex Receives FDA Approval for Generic Infuvite Pediatric Injection with 180-Day Exclusivity
Ascletis Completes Enrollment for ASC30 Oral GLP-1 Diabetes Drug Phase II Trial
Ascletis Completes Enrollment in Phase II Trial of ASC30 Oral GLP-1 Diabetes Drug
Veradermics VDPHL01 Phase 2/3 Trial Results for Male Pattern Hair Loss to Be Announced
Veradermics VDPHL01 Phase 2/3 Trial Results: Conference Call Scheduled for Oral Minoxidil Hair Loss Treatment
Adagio Medical's vCLAS Ventricular Ablation System Shows 84% Success Rate in Pivotal Trial for Heart Arrhythmia Treatment
Atara Biotherapeutics Faces Securities Class Action Lawsuit with May 2026 Deadline for Lead Plaintiff Applications
Aquestive Therapeutics Faces Class Action Lawsuit Over Alleged FDA Application Misrepresentations
Pulse Biosciences nPulse Cardiac Catheter Shows High Durability in Heart Rhythm 2026 Trial Data